The global Prostate Cancer Diagnostics Solution market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 22860 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.

Prostate Cancer Diagnostics Solution Market

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate cancer diagnostics solution refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

North American market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Prostate Cancer Diagnostics Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Prostate Cancer Diagnostics Solution in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics Solution.

Report Scope

The Prostate Cancer Diagnostics Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Diagnostics Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Diagnostics Solution Market Report

Report Metric	Details
Report Name	Prostate Cancer Diagnostics Solution Market
Accounted market size in 2023	US$ 13430 million
Forecasted market size in 2030	US$ 22860 million
CAGR	7.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tumor Biomarker Tests Imaging Biopsy Other
Segment by Application	Age Below 55 Age 55-75 Age Above 75
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Diagnostics Solution Market growing?

Ans: The Prostate Cancer Diagnostics Solution Market witnessing a CAGR of 7.8% during the forecast period 2024-2030.

What is the Prostate Cancer Diagnostics Solution Market size in 2030?

Ans: The Prostate Cancer Diagnostics Solution Market size in 2030 will be US$ 22860 million.

Who are the main players in the Prostate Cancer Diagnostics Solution Market report?

Ans: The main players in the Prostate Cancer Diagnostics Solution Market are OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics

What are the Application segmentation covered in the Prostate Cancer Diagnostics Solution Market report?

Ans: The Applications covered in the Prostate Cancer Diagnostics Solution Market report are Age Below 55, Age 55-75, Age Above 75

What are the Type segmentation covered in the Prostate Cancer Diagnostics Solution Market report?

Ans: The Types covered in the Prostate Cancer Diagnostics Solution Market report are Tumor Biomarker Tests, Imaging, Biopsy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tumor Biomarker Tests

1.2.3 Imaging

1.2.4 Biopsy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Prostate Cancer Diagnostics Solution Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2019-2030)

2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region

2.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Diagnostics Solution Market Dynamics

2.3.1 Prostate Cancer Diagnostics Solution Industry Trends

2.3.2 Prostate Cancer Diagnostics Solution Market Drivers

2.3.3 Prostate Cancer Diagnostics Solution Market Challenges

2.3.4 Prostate Cancer Diagnostics Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue

3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2019-2024)

3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue

3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio

3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2023

3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served

3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service

3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics Solution Breakdown Data by Type

4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Diagnostics Solution Breakdown Data by Application

5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Diagnostics Solution Market Size (2019-2030)

6.2 North America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)

6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2019-2030)

7.2 Europe Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)

7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2019-2030)

8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024)

8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2019-2030)

9.2 Latin America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)

9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2019-2030)

10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024)

10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 OPKO

11.1.1 OPKO Company Detail

11.1.2 OPKO Business Overview

11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction

11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.1.5 OPKO Recent Development

11.2 Genomic Health

11.2.1 Genomic Health Company Detail

11.2.2 Genomic Health Business Overview

11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction

11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.2.5 Genomic Health Recent Development

11.3 Abbott

11.3.1 Abbott Company Detail

11.3.2 Abbott Business Overview

11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction

11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.3.5 Abbott Recent Development

11.4 Beckman Coulter

11.4.1 Beckman Coulter Company Detail

11.4.2 Beckman Coulter Business Overview

11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction

11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.4.5 Beckman Coulter Recent Development

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Detail

11.5.2 Siemens Healthcare Business Overview

11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction

11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.5.5 Siemens Healthcare Recent Development

11.6 bioMeriux

11.6.1 bioMeriux Company Detail

11.6.2 bioMeriux Business Overview

11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction

11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.6.5 bioMeriux Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction

11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.7.5 Roche Recent Development

11.8 MDx Health

11.8.1 MDx Health Company Detail

11.8.2 MDx Health Business Overview

11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction

11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.8.5 MDx Health Recent Development

11.9 DiaSorin

11.9.1 DiaSorin Company Detail

11.9.2 DiaSorin Business Overview

11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction

11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.9.5 DiaSorin Recent Development

11.10 Myriad Genetics

11.10.1 Myriad Genetics Company Detail

11.10.2 Myriad Genetics Business Overview

11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction

11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.10.5 Myriad Genetics Recent Development

11.11 Ambry Genetics

11.11.1 Ambry Genetics Company Detail

11.11.2 Ambry Genetics Business Overview

11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction

11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024)

11.11.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tumor Biomarker Tests

Table 3. Key Players of Imaging

Table 4. Key Players of Biopsy

Table 5. Key Players of Other

Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2019-2024)

Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2025-2030)

Table 12. Prostate Cancer Diagnostics Solution Market Trends

Table 13. Prostate Cancer Diagnostics Solution Market Drivers

Table 14. Prostate Cancer Diagnostics Solution Market Challenges

Table 15. Prostate Cancer Diagnostics Solution Market Restraints

Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Prostate Cancer Diagnostics Solution Market Share by Players (2019-2024)

Table 18. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2023)

Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service

Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2019-2024)

Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2025-2030)

Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2019-2024)

Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2025-2030)

Table 33. North America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2025-2030) & (US$ Million)

Table 48. OPKO Company Detail

Table 49. OPKO Business Overview

Table 50. OPKO Prostate Cancer Diagnostics Solution Product

Table 51. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 52. OPKO Recent Development

Table 53. Genomic Health Company Detail

Table 54. Genomic Health Business Overview

Table 55. Genomic Health Prostate Cancer Diagnostics Solution Product

Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 57. Genomic Health Recent Development

Table 58. Abbott Company Detail

Table 59. Abbott Business Overview

Table 60. Abbott Prostate Cancer Diagnostics Solution Product

Table 61. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. Beckman Coulter Company Detail

Table 64. Beckman Coulter Business Overview

Table 65. Beckman Coulter Prostate Cancer Diagnostics Solution Product

Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 67. Beckman Coulter Recent Development

Table 68. Siemens Healthcare Company Detail

Table 69. Siemens Healthcare Business Overview

Table 70. Siemens Healthcare Prostate Cancer Diagnostics Solution Product

Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 72. Siemens Healthcare Recent Development

Table 73. bioMeriux Company Detail

Table 74. bioMeriux Business Overview

Table 75. bioMeriux Prostate Cancer Diagnostics Solution Product

Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 77. bioMeriux Recent Development

Table 78. Roche Company Detail

Table 79. Roche Business Overview

Table 80. Roche Prostate Cancer Diagnostics Solution Product

Table 81. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 82. Roche Recent Development

Table 83. MDx Health Company Detail

Table 84. MDx Health Business Overview

Table 85. MDx Health Prostate Cancer Diagnostics Solution Product

Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 87. MDx Health Recent Development

Table 88. DiaSorin Company Detail

Table 89. DiaSorin Business Overview

Table 90. DiaSorin Prostate Cancer Diagnostics Solution Product

Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 92. DiaSorin Recent Development

Table 93. Myriad Genetics Company Detail

Table 94. Myriad Genetics Business Overview

Table 95. Myriad Genetics Prostate Cancer Diagnostics Solution Product

Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 97. Myriad Genetics Recent Development

Table 98. Ambry Genetics Company Detail

Table 99. Ambry Genetics Business Overview

Table 100. Ambry Genetics Prostate Cancer Diagnostics Solution Product

Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2019-2024) & (US$ Million)

Table 102. Ambry Genetics Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2023 VS 2030

Figure 3. Tumor Biomarker Tests Features

Figure 4. Imaging Features

Figure 5. Biopsy Features

Figure 6. Other Features

Figure 7. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2023 VS 2030

Figure 9. Age Below 55 Case Studies

Figure 10. Age 55-75 Case Studies

Figure 11. Age Above 75 Case Studies

Figure 12. Prostate Cancer Diagnostics Solution Report Years Considered

Figure 13. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2023 VS 2030

Figure 16. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2023

Figure 17. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2023

Figure 19. North America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)

Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)

Figure 25. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Region (2019-2030)

Figure 33. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)

Figure 41. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Country (2019-2030)

Figure 45. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions